The model was based on seven predictor variables: residual disease after primary surgery, International Federation of Gynecology and Oncology (FIGO) stage, tumor histology, age, albumin, family history suggestive of hereditary breast and ovarian cancer (HBOC) syndrome, and American Society of Anesthesiologists (ASA) physical status [5]. The gene discussed is ALB; the disease is neoplasm.